A phase III study by the Norwegian Lung Cancer Group:: Pemetrexed plus carboplatin vs. gemcitabine plus carboplatin as firstline chemotherapy in stage IIIB/IV non-small cell lung cancer

被引:3
|
作者
Gronberg, Bjorn H.
Bremnes, Roy
Aasebo, Ulf
Brunsvig, Paal
Flotten, Oystein
Hjelde, Harald
Wammer, Finn
Stornes, Froydis
Tollali, Terje
Sundstrom, Stein
机构
[1] Norwegian Univ Sci & Technol, St Olavs Univ Hosp, Trondheim, Norway
[2] Univ hosp N Norway, Tromso, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
[4] Haukeland Hosp, N-5021 Bergen, Norway
[5] St Olavs Univ Hosp, Trondheim, Norway
[6] Alesund Hosp, Alesund, Norway
[7] Ullevaal Univ Hosp, Oslo, Norway
[8] Bodo Hosp, Bodo, Norway
关键词
D O I
10.1097/01.JTO.0000283107.93256.5d
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S317 / S317
页数:1
相关论文
共 50 条
  • [1] Pemetrexed plus carboplatin versus gemcitabine plus carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer
    Gronberg, B. H.
    Bremnes, R.
    Aasebo, U.
    Brunsvig, P.
    Flotten, O.
    Hjelde, H.
    Wammer, F.
    Stornes, F.
    Tollali, T.
    Sundstrom, S. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial
    Zatloukal, P
    Petruzelka, L
    Zemanová, M
    Kolek, V
    Skricková, J
    Pesek, M
    Fojtu, H
    Grygárková, I
    Sixtová, D
    Roubec, J
    Horenková, E
    Havel, L
    Prusa, P
    Nováková, L
    Skácel, T
    Kuta, M
    [J]. LUNG CANCER, 2003, 41 (03) : 321 - 331
  • [3] Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer
    Gronberg, Bjorn H.
    Bremnes, Roy M.
    Flotten, Oystein
    Amundsen, Tore
    Brunsvig, Paal Fr.
    Hjelde, Harald H.
    Kaasa, Stein
    von Plessen, Christian
    Stornes, Froydis
    Tollali, Terje
    Wammer, Finn
    Aasebo, Ulf
    Sundstrom, Stein
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3217 - 3224
  • [4] A phase lb study of bavituximab plus carboplatin and pemetrexed in chemotherapy naive stage IV non-squamous non-small cell lung cancer
    Grilley-Olson, Juneko
    Weiss, Jared
    Stinchcombe, Thomas E.
    Ivanova, Anastasia
    Tynan, Maureen
    Shan, Joseph
    Socinski, Mark A.
    [J]. CANCER RESEARCH, 2012, 72
  • [5] A Phase Ib Study Of Bavituximab Plus Carboplatin And Pemetrexed In Chemotherapy Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer
    Grilley-Olson, J.
    Weiss, J.
    Stinchcombe, T.
    Ivanova, A.
    Shan, J.
    Villaruz, L.
    Socinski, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S318 - S318
  • [6] Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group
    Rudd, RM
    Gower, NH
    Spiro, SG
    Eisen, TG
    Harper, PG
    Littler, JAH
    Hatton, M
    Johnson, PWM
    Martin, WMC
    Rankin, EM
    James, LE
    Gregory, WM
    Qian, W
    Lee, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 142 - 153
  • [7] Gemcitabine plus carboplatin (GCB) versus cisplatin plus vinblastin (CV) in stage IIIB-IV non-small cell lung cancer (NSCLC).
    Grigorescu, AC
    Draghici, NI
    Gutulescu, N
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 110 - 110
  • [8] A Phase Ib study of bavituximab plus carboplatin and pemetrexed in chemotherapy-naive incurable stage IIIb/IV non-squamous non-small cell lung cancer.
    Grilley-Olson, Juneko E.
    Villaruz, Liza C.
    Stinchcombe, Thomas E.
    Weiss, Jared
    Shan, Joseph
    Vashishtha, Anshu
    Ivanova, Anastasia
    Socinski, Mark A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [9] A phase II trial of alternating cycles of carboplatin/paclitaxel and carboplatin/gemcitabine for stage IIIB/IV non-small cell lung cancer
    Ahmad, I.
    Arnold, F.
    Ahmed, S.
    Sami, A.
    Zhu, T.
    Haider, K.
    Yadav, S.
    Gesy, K.
    Brigden, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer
    Scagliotti, GV
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (02) : S5 - S8